TNXP Butterfly Strategy
TNXP (Tonix Pharmaceuticals Holding Corp.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and commercialization of novel therapeutic agents and diagnostic tools, all aimed at combating human illnesses and easing patient discomfort. The company boasts a comprehensive pipeline of potential treatments spanning several key medical fields: immunology, rare conditions, infectious diseases, and central nervous system (CNS) disorders. In the realm of immunology, Tonix is progressing with biologics designed to address organ transplant rejection, various autoimmune diseases, and certain forms of cancer. A prominent candidate here is TNX-1500, a humanized monoclonal antibody targeting CD40-ligand, which is being investigated for its utility in preventing both allograft and xenograft rejection, as well as in treating autoimmune disorders. Its rare disease initiatives include TNX-2900, a specific treatment candidate for Prader-Willi syndrome.
TNXP (Tonix Pharmaceuticals Holding Corp.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $210.7M, a beta of 1.68 versus the broader market, a 52-week range of 10.03-69.97, average daily share volume of 481K, a public-listing history dating back to 2012, approximately 81 full-time employees. These structural characteristics shape how TNXP stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.68 indicates TNXP has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a butterfly on TNXP?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current TNXP snapshot
As of June 30, 2026, spot at $12.79, ATM IV 102.50%, IV rank 28.04%, expected move 29.39%. The butterfly on TNXP below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this butterfly structure on TNXP specifically: TNXP IV at 102.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a TNXP butterfly, with a market-implied 1-standard-deviation move of approximately 29.39% (roughly $3.76 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TNXP expiries trade a higher absolute premium for lower per-day decay. Position sizing on TNXP should anchor to the underlying notional of $12.79 per share and to the trader's directional view on TNXP stock.
TNXP butterfly setup
The TNXP butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TNXP near $12.79, the first option leg uses a $12.15 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TNXP chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TNXP shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $12.15 | N/A |
| Sell 2 | Call | $12.79 | N/A |
| Buy 1 | Call | $13.43 | N/A |
TNXP butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
TNXP butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on TNXP. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on TNXP
Butterflies on TNXP are pinning bets - traders use them when they expect TNXP to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
TNXP thesis for this butterfly
The market-implied 1-standard-deviation range for TNXP extends from approximately $9.03 on the downside to $16.55 on the upside. A TNXP long call butterfly is a pinning play: it pays maximum at the middle strike if TNXP settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current TNXP IV rank near 28.04% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TNXP at 102.50%. As a Healthcare name, TNXP options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TNXP-specific events.
TNXP butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TNXP positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TNXP alongside the broader basket even when TNXP-specific fundamentals are unchanged. Always rebuild the position from current TNXP chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on TNXP?
- A butterfly on TNXP is the butterfly strategy applied to TNXP (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With TNXP stock trading near $12.79, the strikes shown on this page are snapped to the nearest listed TNXP chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TNXP butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the TNXP butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 102.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TNXP butterfly?
- The breakeven for the TNXP butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TNXP market-implied 1-standard-deviation expected move is approximately 29.39%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on TNXP?
- Butterflies on TNXP are pinning bets - traders use them when they expect TNXP to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current TNXP implied volatility affect this butterfly?
- TNXP ATM IV is at 102.50% with IV rank near 28.04%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.